06 Feb 2025White paper This White Paper is intended for all stakeholders of REGEN Biotech, Inc. (“REGEN”). On January 22, 2025, Korea’s IP High Court rendered a judgement in favor of REGEN, finding that KR Patent No. 10-1725279 (Manufacturing method of polymeric microparticles having network structure) held by VAIM Co., Ltd. (“VAIM”) is subject to grounds for invalidation, and therefore the decision of the Intellectual Property and Trial and Appeal Board (“IPTAB”) should be set aside.The application for the foregoing patent was filed on October 27, 2015, and the patent was issued on April 4, 2017. The IP High Court is a court competent to evaluate whether decisions of IPTAB on patent validity/invalidity are proper. Meanwhile, VAIM owns KR Patent No. 10-1481441 (A process for the preparation of polylactic acid microparticles by a spray method). The application for this patent was filed on February 22, 2013, and the patent was issued on January 6, 2015. With respect to this patent, an invalidation action was filed with IPTAB on August 25, 2017. Both IPTAB and the IP High Court ruled that the foregoing patent is invalid. As the Supreme Court dismissed the final appeal on March 2, 2021, the invalidation decision on the patent was rendered final and conclusive, resulting in the extinguishment of the patent rights due to invalidity. As explained above, TO THIS DATE, REGEN has been successfully responding to the lengthy patent litigation with VAIM. In light of this achievement, REGEN is committed to further contributing to customers by supplying high-quality products based on the patents and manufacturing technologies we have developed over the past 10 years. REGEN would also like to express our sincere gratitude to everyone who has supported us throughout this journey.READ MORE
15 Mar 20222022 AMWC World CongressAMWC Congress Monaco! REGEN Biotech, Inc is pleased to invite you on the 20th World Congress of Aesthetic & Anti-Aging Medicine AMWC 2022 to be held in Monaco Grimaldi Forum form 31 March to 2 April. Visit our booth [ R20 at ATRIUM ] and check out the our product - new generation bio-stimulator AestheFill & PowerFill.Looking forward to seeing you all from 31 March, 2022. READ MORE
R&D forms the foundation of our products’ strength. Our team’s dedication to strong research is the reason why we could formulate solutions that cater to different needs. Our goal is to deliver results. We aim to create safe and effective solutions in which our clients can see and feel real results.
All of
Regen starts fromR&D
R&D forms the foundation of our products’ strength. Our team’s dedication to strong research is the reason why we could formulate solutions that cater to different needs. Our goal is to deliver results. We aim to create safe and effective solutions in which our clients can see and feel real results.
Our solution for skin health and restoration utilizes safe ingredients with advanced skin technology. Similarly, our innovative physical enhancement products are powered by breakthrough formula and creativity.